Hide

FocusBar

Subscribe to Premium Member
Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M616Revenue $M311Net Margin (%)-120.9Z-Score-3.6
Enterprise Value $M850EPS $-2.4Operating Margin %-104.4F-Score1
P/E(ttm))0Cash Flow Per Share $-1.6Pre-tax Margin (%)-120.9Higher ROA y-yN
Price/Book17.810-y EBITDA Growth Rate %7.0Quick Ratio7.7Cash flow > EarningsY
Price/Sales1.95-y EBITDA Growth Rate %31.6Current Ratio5.2Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-54.6Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-1,137.2Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M156ROI % (ttm)-39.9Gross Margin Increase y-yN

Gurus Latest Trades with DNDN

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Number of guru portfolios checked: 51.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DNDNJohn Burbank 2012-09-30 Sold Out -0.13%$4.27 - $7.43
($5.44)
$ 3.89-28%Sold Out0
DNDNPRIMECAP Management 2012-09-30 Reduce-0.02%$4.27 - $7.43
($5.44)
$ 3.89-28%Reduce -28.95%4,427,800
DNDNPRIMECAP Management 2012-06-30 Reduce-0.04%$5.83 - $11.8
($8.62)
$ 3.89-55%Reduce -28.51%6,231,930
DNDNJohn Burbank 2012-03-31 Buy 0.18%$7.6 - $16.53
($11.76)
$ 3.89-67%New holding, 500000 sh.500,000
DNDNGeorge Soros 2011-12-31 Sold Out -0.03%$6.55 - $11.29
($8.54)
$ 3.89-54%Sold Out0
DNDNGeorge Soros 2011-09-30 Reduce-1.33%$9.12 - $41.64
($21.66)
$ 3.89-82%Reduce -92.85%185,000
DNDNGeorge Soros 2011-06-30 Reduce-1.22%$36.86 - $43.43
($39.78)
$ 3.89-90%Reduce -44.64%2,586,366
DNDNGeorge Soros 2011-03-31 Add0.21%$31.85 - $38.2
($34.58)
$ 3.89-89%Add 11.27%4,671,699
DNDNPRIMECAP Management 2011-03-31 Add0.08%$31.85 - $38.2
($34.58)
$ 3.89-89%Add 26.03%7,544,649
DNDNGeorge Soros 2010-12-31 Add1.08%$33.84 - $41.22
($37.07)
$ 3.89-90%Add 131.15%4,198,696
DNDNGeorge Soros 2010-09-30 Buy 1.12%$27.31 - $42.58
($36.97)
$ 3.89-90%New holding, 1816463 sh.1,816,463
DNDNGeorge Soros 2010-06-30 Sold Out -0.01%$33.59 - $55.43
($41.29)
$ 3.89-91%Sold Out0
DNDNGeorge Soros 2010-03-31 Buy 0.01%$26.28 - $37.818
($31.88)
$ 3.89-88%New holding, 11938 sh.11,938
DNDNPRIMECAP Management 2009-09-30 Add0.06%$22.13 - $29.46
($24.3)
$ 3.89-84%Add 32.23%4,554,500
DNDNPRIMECAP Management 2009-06-30 Add0.08%$4.14 - $26.08
($19.93)
$ 3.89-80%Add 88.15%3,444,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DNDN is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
DNDN PRIMECAP Management 2013-03-313,789,8002.430.03-5.11%
Premium Most recent portfolio changes are included for Premium Members only!


DNDN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
CANET GERARDODirector 2012-08-01Buy10,000$4.38-10.73view
Frohlich Mark WSee Remarks 2012-04-23Sell2,687$10.56-62.97view
Frohlich Mark WSee General Remarks 2012-01-23Sell3,230$13.24-70.47view
BAYH SUSAN BDirector 2011-09-09Buy20,000$11.05-64.62view
GOLD MITCHELLPresident & Chief Executive Of 2011-07-25Sell19,000$38.37-89.81view
Frohlich Mark WSee General Remarks 2011-07-21Sell3,230$39.13-90.01view
URDAL DAVIDSVP, Chief Scientific Officer 2011-07-21Sell1,015$38.75-89.91view
URDAL DAVIDSVP, Chief Scientific Officer 2011-07-17Sell7,347$38.98-89.97view
GOLD MITCHELLPresident & Chief Executive Of 2011-06-27Sell19,000$38.69-89.89view
CANET GERARDODirector 2011-06-03Sell5,000$41.38-90.55view

Press Releases about DNDN:

Quarterly/Annual Reports about DNDN:

News about DNDN:

Articles On GuruFocus.com
Idenix: Strong Pipeline Will Reward Investors Apr 24 2012 
Dendreon Could Push Higher If New Drug Trials Succeed Apr 23 2012 
Dendreon Could Slip On Shrinking Market For Provenge Apr 22 2012 
Weekly Guru Bargains Highlights: DNDN, AUQ, RFMD, PT, INFA Jan 16 2012 
PRIMECAP Odyssey Funds Letter to Shareholders, Discusses Health Care, IT Jan 10 2012 
Weekly Guru Bargains Highlights: FTR, HUN, HFC, DNDN, PEGA Jan 09 2012 
Options III: Strategy for the Long Term - Writing Covered Calls Oct 17 2011 
Thursday Value Overview Aug 04 2011 
Wednesday Value Overview Jul 27 2011 
Tuesday Value Overview Jul 26 2011 

More From Our Partners
Bayer's Xofigo Cleared in the US - Analyst Blog May 16 2013 - ZACKS

Add Notes, Comments or Ask Questions

Comments

No comment yet
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial
FEEDBACK